Item

HORIZON-01: a phase I-III platform study evaluating the efficacy and safety of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non-small cell lung cancer (NSCLC)

Popat, S.
Januszewski, A.
Cove-Smith, L.
Baijal, S.
Imseeh, G.
Gay, C.
Kerr, K.
Kato, T.
Paz-Ares, L.
Zhou, C. C.
... show 4 more
Keywords
Type
Meetings and Proceedings
Citation
Popat S, Januszewski A, Cove-Smith L, Baijal S, Imseeh G, Gay C, et al. HORIZON-01: a phase I-III platform study evaluating the efficacy and safety of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam, Netherlands). 2025 FEB;200:162-+. PubMed PMID: WOS:001461207900031. English.
Journal Title
Journal ISSN
Volume Title
Embedded videos